The organic matrix of bone contains several protein families, includin
g collagens, proteoglycans, and glycoproteins, all of which may be ext
ensively modified by posttranslational events, such as phosphorylation
and sulfation. Many of the glycoproteins contain Arg-Gly-Asp (RGD), t
he integrin-binding sequence, within their structure, whereas other co
nstituent proteins contain gamma-carboxyglutamic acid. The deposition
of bone matrix by cells in the osteoblastic lineage is regulated by ex
trinsic factors, such as systemic and local growth factors and physica
l forces, and factors that are intrinsic to the cell, such as position
in the cell cycle, maturational stage, and developmental age of the d
onor. Recent studies of several bone matrix gene promoters have identi
fied cis- and trans-acting elements that are responsible for gene acti
vity, although the precise sequence of regulatory events is not known.
Development of in vitro assays, coupled with studies of the appearanc
e of these proteins during development in vivo, provides insight into
the functions of these proteins during the various stages of bone meta
bolism. Potential roles for these proteins include proliferation and m
aturation of stem cells, formation of matrix scaffolding elaborated by
bone-forming cells, modeling, and remodeling. Changes in the function
al properties of the extracellular matrix may be involved in a variety
of disease processes, including osteoporosis and oral bone loss.